MHRA Class 3 Medicines Recall: Eldepryl 5mg Tablets (Orion Pharma (UK) Ltd)
MHRA Class 3 Medicines Recall: Eldepryl 5mg Tablets (Orion Pharma (UK) Ltd)
Drug alert number: EL(24)A/42
Date issued: 18 September 2024
The Medicines and Health products Regulatory Agency (MHRA) has issued a Class 3 medicines defect information notice for: Eldepryl 5mg Tablets (Orion Pharma (UK) Ltd)
Company name: Orion Pharma (UK) Ltd
Product name: Eldepryl 5mg Tablets, PL 27925/0004
SNOMED Code: 669511000001106
| Batch Number | Expiry Date | Pack Size | First Distributed |
| 2167829 | 07.2026 | 100 tablets | 22.09.2023 |
Active Pharmaceutical Ingredient: Selegiline hydrochloride
Brief description of the problem
Orion Pharma (UK) Ltd is recalling the above batch as a precautionary measure due to an out of specification result in the assay result during the follow up stability study of the batch. Only the batch in the table is affected.
Advice for healthcare professionals
Stop supplying the above batch immediately. Quarantine all remaining stock and return it to your supplier using your supplier’s approved process.
View full alert here.
Advice for patients
No further action is required by patients as this is a Pharmacy and Wholesaler level recall. Patients should continue to take medicines from these batches as prescribed by your healthcare professional.
Patients who experience adverse reactions or have any questions about the medication, should seek medical attention. Any suspected adverse reactions should also be reported via the MHRA Yellow Card scheme.
Further Information
For medical information enquiries please email UK.MedicalInformation@orionpharma.com, or telephone 01635 520300.
For stock control enquiries please email orionukar&customerservices@orionpharma.com.
